Henry Kravis and George Roberts step down as KKR chief

[ad_1] Henry Kravis and George Roberts, whose sword-effect buyouts in the 1980s made them the face of the private equity industry, are stepping down as co-CEOs of KKR, the eponymous company that they founded in 1976. Long-time company co-chairs Scott Nuttall and Joe Bae will jointly take the helm, KKR announced Monday. Kravis and Roberts … Read more

Merck asks FDA to clear promising Covid-19 pill

[ad_1] Merck & Co. and its partner Ridgeback Biotherapeutics LP said on Monday they filed a request asking U.S. health regulators to clear their Covid-19 pill, the next step towards adding a long-sought-after drug for use to the House. The filing comes shortly after data from an advanced study showed that the antiviral drug, molnupiravir, … Read more

Evergrande woes hit Chinese real estate bonds | WION French News | Latest news from the world | World Business Watch – WION

[ad_1] Evergrande woes hit Chinese real estate bonds | WION English News | Latest news from the world | World Business WatchWION Beyond Evergrande, China’s real estate market faces a $ 5,000 billion calculationThe Wall Street Journal Chinese real estate bonds plunge as Evergrande debt holders wait for coupon deadlineReuters Harbin among first Chinese cities … Read more

Stock futures fall as energy prices rise

[ad_1] Find out what clicks on FoxBusiness.com. US equity futures fell as crude oil and natural gas prices continued their ascent. S&P 500 futures were down 0.2% and Dow Jones Industrial Average futures were down 0.1%. Contracts do not necessarily predict market movements after the opening bell. In Europe, the Stoxx Europe 600 meandered past … Read more

AstraZeneca antibody cocktail succeeds in advanced stage study to treat COVID-19

[ad_1] Oct. 11 (Reuters) – AstraZeneca’s (AZN.L) investigational drug COVID-19 helped reduce the risk of serious illness or death in an advanced study, the British drugmaker said on Monday, a boost to its efforts to develop coronavirus drugs beyond vaccines. The drug, a cocktail of two antibodies called AZD7442, reduced the risk of severe COVID-19 … Read more